26,034 reports of this reaction
3.3% of all DUPILUMAB reports
#6 most reported adverse reaction
DRUG INEFFECTIVE is the #6 most commonly reported adverse reaction for DUPILUMAB, manufactured by sanofi-aventis U.S. LLC. There are 26,034 FDA adverse event reports linking DUPILUMAB to DRUG INEFFECTIVE. This represents approximately 3.3% of all 782,562 adverse event reports for this drug.
Patients taking DUPILUMAB who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among DUPILUMAB users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for DUPILUMAB:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 26,034 FDA reports for DUPILUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 3.3% of all adverse event reports for DUPILUMAB, making it a notable side effect.
If you experience drug ineffective while taking DUPILUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.